Intravenous immunoglobulin therapy improves long-term outcome in dilated cardiomyopathy by modulating cardiac immune cell function. An update of a randomized placebo-controlled study.
30 August 2024 (09:22 - 09:33)
Organised by: 
Slides
About the speaker
Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
7 More presentations in this session
Professor M. Kerneis (Paris, FR)
Doctor A. Fiolet (Utrecht, NL)
Mr N. Mohammadnia (Nijmegen, NL)
Access the full session
The Event
ESC Congress 2024
30 August 2024
09:22 CET
You may be interested in
Congress Presentation
Congress Session
